Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin with FOLFIRI and Cetuximab in mCRC
NCT01523639Phase 2Terminated
- Sponsor
- Austrian Breast and Colorectal Cancer Study Group
- Start
- Apr 2012
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in colorectal cancer (CRC), sponsored by Austrian Breast and Colorectal Cancer Study Group. Started Apr 2012; status: terminated.
02
Drugs
metformin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01523639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01523639.